-
1.
公开(公告)号:US20240116922A1
公开(公告)日:2024-04-11
申请号:US18269073
申请日:2021-12-21
Applicant: BIOGEN MA INC.
Inventor: Emily Anne Peterson , Magnus Pfaffenbach , Fang Gao , Philippe Bolduc , Zhili Xin , Ryan Evans
IPC: C07D471/04 , A61K45/06 , C07D487/04
CPC classification number: C07D471/04 , A61K45/06 , C07D487/04
Abstract: This disclosure relates to imidazo[1,2-a]pyridinyl derivatives of formula (I), or pharmaceutically acceptable salts thereof, Formula (I) in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The disclosure further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
-
公开(公告)号:US20230002361A1
公开(公告)日:2023-01-05
申请号:US17623182
申请日:2020-06-24
Applicant: BIOGEN MA INC.
Inventor: Emily Anne Peterson , Ryan Evans , Fang Gao , Philippe Bolduc , Magnus Pfaffenbach , Zhili Xin
IPC: C07D405/14 , C07D471/04 , C07D401/12 , C07D487/04 , C07D519/00
Abstract: This invention relates to 2H-indazole Derivatives of formula (I′), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
-
公开(公告)号:US20230087118A1
公开(公告)日:2023-03-23
申请号:US17623181
申请日:2020-06-24
Applicant: BIOGEN MA INC.
Inventor: Emily Anne Peterson , Ryan Evans , Fang Gao , Philippe Bolduc , Magnus Pfaffenbach , Zhili Xin , Tricia May-Dracka
IPC: C07D471/04 , C07D487/04 , A61K31/437 , A61K31/4985 , A61K45/06 , C07D519/00 , A61K31/519
Abstract: This invention relates to Imidazo[1,2-a]pyridinyl Derivatives of formula (I′), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
-
公开(公告)号:US20220089592A1
公开(公告)日:2022-03-24
申请号:US17421348
申请日:2020-01-17
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Magnus Pfaffenbach , Tricia May-dracka , Ryan Evans , Fang Gao , Istvan Enyedy , Zhili Xin , Philippe Bolduc , Emily Anne Peterson
IPC: C07D471/04 , C07D519/00 , C07D487/04
Abstract: This invention relates to Imidazo[1,2-a]pyridinyl Derivatives of formula (I′), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
-
-
-